Purpose of the development: Lektivir - a drug based on bacterial lectins is designed to prevent and treat influenza, herpes, hepatitis C and immunodeficiencies of various etiologies.

Recommended application field: Medicine.

Advantages over analogues: Highly effective preparation.

The development stage readiness: Introduced in production

Technical and economic effect: Патенты Украины. Технические условия. Инструкция по применению. Государственная регистрация препарата.

Description of the development:
()
Lectins have unique specificity for different types of sialic acids and natural sialokonyugatov may also be used as analytical reagents for the purification and study of glycoproteins as probes for studying the molecular structure of the surface of the cell. Bacterial lectins - The technology of bacterial lectins with unique specificity for different types of sialic acids and natural sialokonyugatov . Lectins obtained can be used as analytical reagents for the study and purification of glycoproteins as molecular probes in the study of the structure of the cell surface , as well as promising therapeutic and prophylactic drugs for viral infections and immune deficiency of various etiologies . Patents of Ukraine. Specifications.

Information about newness of the development:
there are Ukrainian patents -- 2 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Licence's sale
Technological document's sale
Creation of joint enterprise
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua